Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Can you even imagine that PSTI is closing Down today after all of this amazing data and top-secret dot-connecting from the YAKIKAKI insider allooneytoon?!?!
No Controller Required.................
A miracle couldn't revive this comatose corpse.
You can fool some of the people some of the time....
Havn't seen these types of data since the Pre-eclampsia and Bruegers Disease Studies and orphan designations....
Looks like SpideyBoy died today. So sad.
So much amazing data... Novo buying psti... and knowbody cars. We can't even reach AVERAGE VOLUME and cross $1.20.
Even the 'controller' had little to do today. Told you ALL that Monday would be a bust, as usual.
PSTIs the Merry band of misfits here are into reruns and repeats, the pattern discovered and exposed. Fake right, go left. Distract with "New" discoveries as the last "new" discoveries fall of the radar. (pun intended)
Anyone hear YAKI may be leaving?
It's just 1 Big Shell Game, but investors are getting WISE, quickly.
OMG... didn't even make the PP Presentation...... To the moon, Alice.
Oh you swing all right... The bid and ask are $1.17/$1.18...
and now we are touting diabetes... What a silly easy to read pattern...
Tout
Miss
Distract
Dillute.
Rinse and repeat.
Diabetes Indication? 8 years if P1 starts by June.
Take a look at 2016... If projects an approval and sales....... 2018.
BS, this is classic can kicking down the road... A contact would have Days and time of commencement. You know full well that would be a plus release, not an 11th grade PP Presentation...
"Start in 2019" is pretty general. Is that January 1st or December 31st? X 3 YEARS..............
Results so powerful
The share price might cross $1.21 with near-average volume.!!!!
Clearly, Analysts and Investors are enthusiastic and buying hands over first.... Hooooooo Rah.
. Grants being repaid
. Deadlines missed
. Share Price falling
. Cash reserves dwindling
. Partnerships terminated
. Expectations missed
. Promises erased
. Capacity not sufficient
. Analysts dropping
. Institutions decreasing
. Compensation increasing
. Longterm investors bailing
. Incompetence growing
. Patience decreasing
. Confidence failing
Connect the dots....
Drip...Drip...Drip...Drip...circling the drain in death spiral formation.
FDApproved
Thursday, 08/16/18 08:21:03 AM
Re: None
0
Post # of 18257
Nearly 30 Million In Cash..That's 1 1/2 Years At 5 Million Per Quarter ! Get A Clue.. No Clue..Hopester You !
Another Guru Snafu...
FDApproved
Wednesday, 08/29/18 12:43:53 PM
Re: None
0
Post # of 18256
IMO..PSTI May Have Just Received A RMAT In The Last Few Weeks Or If Not, It Is Imminent ! September May Bring Good News ?
And another...
FDApproved
Thursday, 08/30/18 09:51:10 AM
Re: None
0
Post # of 18255
IMO...CLI Approval Coming In A Matter Of Months !
If we consider the source of all of these 'Big Announcements' and super secret finds by the sites perpetual poster...
We need many more grains of salt... Swing and a miss. AGAIN.
FDApproved
Sunday, 09/16/18 01:20:21 PM
Re: None
0
Post # of 18251
It Sure Looks Like They Got The Sosei Deal Done ??? We Shall See Tomorrow ?
Does one even read what they post.
NOPE! That would spoil the big fun GS & BS. That is exactly what it says, Scott. So instead of believing the perfectly sound and correct description provided by TF, the play is to disregard what TF is reporting as a 'LIE', even though its material, and then grasp for straws to link it to psti.
The even funnier part is that this 'rush' is supposedly for PLX-IMMUNE?? From the ACS Really?? Why no 'rush' for PLX-R18????
My intuition on R18 and the DOD tells me GREED, plain and simple, is the holdup. I can just see YakiZami demanding some outrageous price from the US Gov't. for a contract that is so outrageous, it has stopped progress. Essentially holding every American, hostage and at risk of radiation poisoning, especially the Armed Forces in harms way... Totally fits these 2.
Lots Of Job Openings At The Brand
Your confusing everyone fda. In past posts you have been VERY clear that the ONLY purpose of the TF deal is to produce better serum media since PSTI 'goes it alone' with its 150,000 doses per year mfg. capabilities.
You have made it clear that TF would not be manufacturing for PSTI.
Please clarify TF's 'deal' and what specifically TF is 'contracted' to provide for psti.
I'd guess the $1.30 area would be the target.
What's a sh px ?
Blah,ha,ha
In doing the DD you requested FDApproved…
It seems you forgot to metion your 'efficacy claim' of AFS 85.2% was NOT statistically significant compared to the 'historical' control group - and without a placebo control group... you've made a 'false claim of efficacy' again. a TREND is the strongest language provided...
Rate (AFSR) at 1 year post treatment, relative to a historical control group of 66.8% AFSR. A pivotal South Korean Phase 2/3 trial in CLI is about to initiate, pending regulatory approval.
"Although these were early stage trials, some indication of efficacy in reducing the frequency of amputations were also found. AFS, or Amputation Free Survival is the standard primary endpoint in pivotal phase trials of CLI according to the FDA and the EMA, and these two studies showed an AFS rate at one year of 86% in PLX-treated patients versus an AFS ranging between 48% to 81% in patients from placebo arms in other trials."
Thanks For The Laughs ! Pluristem Reports 85.2 Amputation Free Survival Rate After 1 Year In Phase 1 CLI Trial !
Potential to present interim data from Phase 2 trial in Intermittent Claudication (2H15)
Right on time!!
Newsworthy Events and Milestones for 2014-2015
http://pluristem.netron-webs.com/images/H.C.Wainwright_Initiation_Coverage_Sept_8_2014.pdf
PLX-PAD: ? Enroll first patient in South Korean arm of Phase 2 trial in IC (1H14) ?
Potential regulatory approval to initiate South Korean Phase 2/3 CLI trial (1H15) ?
Potential regulatory approval to initiate Phase 1 study in Preeclampsia (2H14) ?
Potential regulatory approval to initiate pivotal trial surgery-related muscle injury (1H15) ?
Potential for United Therapeutics to present Phase 1 data from PAH trial (1H15) ?
Potential to present interim data from Phase 2 trial in Intermittent Claudication (2H15)
PLX-RAD: ? Potential to file IND for Phase 1 trial of PLX-RAD in ARS (1H15)
IN MICE. OH MY.
Thanks For The Laughs ! Pluristem Reports 85.2 Amputation Free Survival Rate After 1 Year In Phase 1 CLI Trial !
83% improvement in MWD at 52 weeks compared to baseline
Sorry, but CMS will NEVER pay for IC if THIS is the endpoint psti is hanging their hat on. Sorry... but this is pathetic.
How much would that cost the government per STEP?
hopester, please calculate the "Number of STEPs that an 83% improvement" will give a patient and then shart it for us with axis for cost of drug and reimbursement rates. thx
SAD but TRUE.
FDApproved
Saturday, 11/10/18 11:11:48 AM
Re: None
0
Post # of 18199
Patients treated with 2 doses of 300×106 cells originating from different placentae showed a statistically significant 42% difference in MWD at week 52 compared to patients receiving placebo, and also demonstrated a statistically significant 83% improvement in MWD at 52 weeks compared to baseline
Scott, NO we did not see anything new. And yes... HUGE conflicts for being on the zamiyaki dole...
The reason this was chosen as the "1" indication to persue is because it was supposed to be a 'lay-up', easiest to demonstrate efficacy as well as produce 'upside surprises' in collateral data. IMHO.
NOT working out so well... These results relative to the lay-up expectations at psti, are unremarkable...
Oh, yes, almost forgot. IF you don't believe me, the 'MARKET' and 'Analysts' will provide their 'Sentiments' for Monday's open.
CHEERS!
What did this mean?
"No arm showed a statistically significant difference from placebo."
And this...
" though not statistically significant compared to placebo."
Doesn't sound good.
Today's PSTI Value and Sentiment of Investors...
Previous Close
1.18
Bid
1.16 x 3200
Gotta love 'them' facts and data... The TRUTH never goes out of style.
ARS is off the table until 2020...
Unfortunately, you are on to them, PLX-11. The 'silence' about R18 'progress' - since that is the key word - is DAMNING in the face of "I have the CURE in my pocket"
There is not a 'safe-harbor' statement anywhere that protects THAT kind of FLAGRENT claim!
BEWARE of the misstress of dillusion and confusion. Mixing and matching bs to smear and cloud the facts about PSTI, its share price & its 'progress'. Shame on you Matilda.
Pluristem Therapeutics Inc. (PSTI)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
In watchlist
1.18-0.01 (-0.84%)
At close: ?November? ?8 3:59PM EST
1.16 -0.02 (-1.69%)
Pre-Market: 8:00AM EST
True. Bad timing on my part.
hopester
Sunday, 10/28/18 01:36:40 PM
Re: A deleted message
0
Post # of 18137
True. Bad timing on my part.
Have no idea what BOG and TOE Means.
Took a flyer and dipped my toes based upon belief of prospects coming sooner than they will. Now more convinced they'll come so this time I'll back up the truck when the "timing " chart/indicators tell me.
Now you hold shares;do you not? But given your're scenario, I've gotta ask why? Puzzling to say the least!
Took a flyer and dipped my toes based upon belief of prospects... (on psti stock without TA, and against recommendations)
This from the guru of TA, FA & DA,! This is guessing investing...
hopester, can you break out your sharts and TA and help with this answer to a GREAT question?
Pluristem Therapeutics Inc. (PSTI)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.18-0.01 (-0.84%)
At close: ?November? ?8 3:59PM EST
1.16 -0.02 (-1.69%)
Pre-Market: 8:00AM EST
If Saturday's PSTI Data Release At The
Too bad the 'Investor Sentiment' has NO anticipation of game-changing 'breaking news'. Fact is MANY posters or presentations are 'embargoed', simply because the 'show' has this as an 'agreement' with the company, that it must first be 'unveiled' at their conference, so they get the highlight as an 'important' conference.
An 'embargo' has NOTHING to do with the 'power' of the data, its impact or influence on a stock, company or share price. The data MAY be significant, but they are mutually exclusive. An 'embargo' is simply, well, an embargo.
It is well understood, that even with an 'embargo', 'someone' knows what the data is long before now, and its likely 'creep' into insider then to closely held then to large shareholders and preferred 'tutes' impacts the SP ahead of the announcement/presentation. Certainly, the first indicator would have been the TASE...
There are NO secrets among thieves.
UNFORTUNATELY, this presentation doesn't seem to have much interest of anticipation of investors. We'll see.
FDApproved
Thursday, 11/08/18 12:48:33 PM
Re: None
0
Post # of 18129
If Saturday's PSTI Data Release At The AHA Conference In Chicago, Demonstrates That PLX-PAD Cells Improved Heart Function In IC Patients With Heart Disease. Then I Will Be Dancing A Viking Jig In My Brand New Platinum Blonde Wig ! I May Even Roast A Pig ?
Pluristem Therapeutics Selected to Present Data from Phase II IC Study at the American Heart Association Scientific Sessions.
https://www.nasdaq.com/press-release/pluristem-therapeutics-selected-to-present-data-from-phase-ii-ic-study-at-the-american-heart-20181018-00281
The only measure of progress that matters...Investor Sentiment!
"The company's shares closed at $1.18. A year ago, they were trading at $1.51."
https://www.zacks.com/ap/PSTI
"Correction, It Was 400K !"
Actually... wrong again allo.
"The biotechnology company posted revenue of $4,000 in the period."
https://finance.yahoo.com/news/pluristem-fiscal-1q-earnings-snapshot-154240334.html
FDApproved
Wednesday, 11/07/18 06:12:24 PM
Re: None
0
Post # of 18107
"Correction, It Was 400K !"
SOLID PROGRESS MADE IN THE 1ST QUARTER REPORT.
Please list the Top 3 'solid progress' indicators you reference:
1)
2)
3)
To measure 'progress' one needs a reference point from which to measure. Please make sure you examples have reference points.
Thanks.
Welcome to investing in psti, jaime9 2000!
There isn't much at psti that follows conventional wisdom with respect for shareholders. Quite the contrary, actually. Do you own DD and see for yourself. Don't feel bad, though - MANY have come before and after you. We've ALL been deceived.
Hang in there, there is always next year! Or, next week, or next month or, or